- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Latebreakers: APhA joins White House to fight drug abuse
Recognizing the growing problem of prescription drug abuse among teenagers, the White House Office of National Drug Control Policy (ONDCP) is partnering with pharmacy organizations to combat the problem.
Recognizing the growing problem of prescription drug abuse among teenagers, the White House Office of National Drug Control Policy (ONDCP) is partnering with pharmacy organizations to combat the problem. Scott Burns, deputy director for state, local, and tribal affairs at ONDCP, joined APhA officials at the recent Atlanta convention to announce APhA involvement in ONDCP's "Parents: The Anti-Drug" campaign. According to a recent ONDCP study, Rx drugs are now the second most popular class of drugs behind marijuana among teens, and new drug abusers are turning to prescription drugs as readily as marijuana.
